ARS Pharmaceuticals Inc (NASDAQ:SPRY)

BATS BZX Real-Time Price
As of 12:19pm ET
 +0.135 / +3.57%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for ARS Pharmaceuticals Inc have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 3.00. The median estimate represents a +2.04% increase from the last price of 3.92.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Hold stock in ARS Pharmaceuticals Inc. This rating has held steady since September, when it was downgraded from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -11.11%
Growthannually 11.88%


Growthquarterly 6,566.67%
Growthannually 95.34%
Key to the earnings and sales forecast charts.